(Q44070285)

29 November 2017

Relationships of apolipoprotein B(100) with the metabolic syndrome in Type 2 diabetes mellitus (English)

1 reference

29 November 2017

1 reference

1 reference

Relimpio F

1

1 reference

29 November 2017

Losada F

2

1 reference

29 November 2017

Pumar A

3

1 reference

29 November 2017

Mangas MA

4

1 reference

29 November 2017

Morales F

5

1 reference

29 November 2017

Astorga R

6

1 reference

29 November 2017

1 September 2002

1 reference

Diabetes Research and Clinical Practice

29 November 2017

1 reference

29 November 2017

57

1 reference

29 November 2017

3

1 reference

29 November 2017

199-207

1 reference

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Management of dyslipidemia in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Hyperlipidaemia in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Association of waist circumference with ApoB to ApoAI ratio in black and white Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Urinary albumin excretion rate and cardiovascular disease in Spaniard type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900096-7

7 January 2021

10.1016/S0168-8227(02)00096-7

Identifiers

DOI

1 reference

29 November 2017

1 reference